Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar-Apr;63(2):147-154.
doi: 10.4103/ijd.IJD_165_17.

Conventional Versus Giant Basal Cell Carcinoma, a Review of 57 Cases: Histologic Differences Contributing to Excessive Growth

J Chase Purnell  1 , Jerad M Gardner  2 , J Ahmad Brown  3 , Sara C Shalin  1
Affiliations

Conventional Versus Giant Basal Cell Carcinoma, a Review of 57 Cases: Histologic Differences Contributing to Excessive Growth

J Chase Purnell et al. Indian J Dermatol. 2018 Mar-Apr.

Abstract

Background: Giant basal cell carcinoma (GBCC) is defined as a basal cell carcinoma (BCC) exceeding 5 cm in size. While these tumors impart significant morbidity due to local tissue destruction and have a higher rate of metastatic disease than their conventional (smaller) counterparts, reasons for their large size remain unclear. While theories relating to neglect or faster growth rate are often invoked; to date, there has not been a comprehensive evaluation of the histologic features of these large tumors that may contribute to their size.

Methods: Histologic features of GBCCs (n = 29) were evaluated and compared to those of conventional BCC (n = 28). Available clinical demographic data were also reviewed.

Results: GBCCs, in addition to overall larger size, more often were thicker, displayed ulceration, and showed a more infiltrative growth pattern than their conventional counterparts. These rare tumors also displayed an insignificant increased propensity for a brisk host immune response, and the infiltrate significantly more often included clusters of plasma cells.

Conclusions: Most histologic features seen in GBCCs likely reflect their large size. Histologic features alone are unlikely to explain the size of these rare tumors. The possibility of an altered host immune response contributing to the growth of these tumors requires further investigation.

Keywords: Basal cell carcinoma; giant basal cell carcinoma; host immune response; plasma cells.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest. What is new? The histologic features of giant basal cell carcinoma reflect their large size, with increased overall size, tumor depth, and ulceration compared to conventional BCC.Tumor microenvironment may provide clues to giant BCC capacity for large size.

Figures

Figure 1
Figure 1
This conventional basal cell carcinoma is of the nodular subtype (Case 8) (H and E, ×100)
Figure 2
Figure 2
This giant basal cell carcinoma shows an infiltrative growth pattern, seen here invading as micronodules and infiltrative cords through atrophic skeletal muscle (Case 10) (H and E, ×100)
Figure 3
Figure 3
A conventional basal cell carcinoma, nodular and infiltrative subtypes, showing focal ductal differentiation within tumor nests (Case 1) (H and E, ×100)
Figure 4
Figure 4
This conventional basal cell carcinoma displays the focal presence of matrical differentiation as evidenced by trichohyaline granules (Case 34) (H and E, ×200)
Figure 5
Figure 5
Tumor infiltration of a large caliber nerve is seen in this example of giant basal cell carcinoma (Case 18) (H and E, ×200)
Figure 6
Figure 6
Tumor cell pleomorphism was detected in a subset of tumors, as seen in this example of a giant basal cell carcinoma. Tumor cell necrosis is also present (Case 46) (H and E, ×400)
Figure 7
Figure 7
Plasma cells were more commonly seen as part of the host response in giant basal cell carcinomas (Case 5) (H and E, ×200)
Figure 8
Figure 8
This giant basal cell carcinoma demonstrates large numbers of plasma cells, including some that have intracytoplasmic Russell bodies (immunoglobulin inclusions) (Case 30) (H and E, ×400)
See this image and copyright information in PMC

References

    1. Archontaki M, Stavrianos SD, Korkolis DP, Arnogiannaki N, Vassiliadis V, Liapakis IE, et al. Giant basal cell carcinoma: Clinicopathological analysis of 51 cases and review of the literature. Anticancer Res. 2009;29:2655–63. - PubMed
    1. Nasser N, Nasser Filho N, Trauczynski Neto B, Silva LM. Giant basal cell carcinoma. An Bras Dermatol. 2012;87:469–71. - PubMed
    1. Randle HW, Roenigk RK, Brodland DG. Giant basal cell carcinoma (T3). Who is at risk? Cancer. 1993;72:1624–30. - PubMed
    1. Anwar U, Al Ghazal SK, Ahmad M, Sharpe DT. Horrifying basal cell carcinoma forearm lesion leading to shoulder disarticulation. Plast Reconstr Surg. 2006;117:6e–9e. - PubMed
    1. Randle HW. Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg. 1996;22:255–61. - PubMed